| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 5,417 | 9,664 | 13,709 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 5,417 | 9,664 | 13,709 | | | Operating Expenses | | Research Development | 26,285 | 36,060 | 35,616 | | Selling General and Administrative | 11,524 | 13,570 | 12,255 | | Non Recurring | 5,783 | 1,563 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (38,175) | (41,530) | (34,161) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,161 | 2,979 | 3,402 | | Earnings Before Interest And Taxes | (37,014) | (38,551) | (30,760) | | Interest Expense | 171 | 210 | 478 | | Income Before Tax | (37,186) | (38,761) | (31,237) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (37,186) | (38,761) | (31,237) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (37,186) | (38,761) | (31,237) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($37,186) | ($38,761) | ($31,237) |
|
0.18% Nasdaq 0.00%
Income Statement
